https://globalinfectiousdisease.com/research/ Published infectious-disease literature filtered to COVID-19. en Wed, 09 Sep 2026 07:02:01 GMT https://globalinfectiousdisease.com/research/articles/10-1002-14651858-cd016384-84f72db7/ https://globalinfectiousdisease.com/research/articles/10-1002-14651858-cd016384-84f72db7/ Tue, 01 Sep 2026 00:00:00 GMT The review offers implications for practice, including communication strategies, training, and supply provision, intended to support policymakers and decision-makers managing IPC during ongoing and future pandemic responses. COVID-19 SARS Influenza Health policy Transmission dynamics Treatment Systematic review https://globalinfectiousdisease.com/research/articles/10-1002-rmv-70185-e1988ad7/ https://globalinfectiousdisease.com/research/articles/10-1002-rmv-70185-e1988ad7/ Tue, 01 Sep 2026 00:00:00 GMT The findings concern a treatment option for immunocompromised patients with persistent infection after monoclonal antibody failure, but the supplied abstract does not establish comparative effectiveness or causality. SARS COVID-19 Vaccination Treatment Systematic review https://globalinfectiousdisease.com/research/articles/10-1002-rmv-70189-831219ed/ https://globalinfectiousdisease.com/research/articles/10-1002-rmv-70189-831219ed/ Tue, 01 Sep 2026 00:00:00 GMT Clarifying these operational parameters supports more precise therapeutic allocation and establishes a methodological framework for managing future infectious disease crises. SARS COVID-19 Vaccination Treatment Transmission dynamics Systematic review https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2026-109103-7003aecc/ https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2026-109103-7003aecc/ Tue, 01 Sep 2026 00:00:00 GMT The findings offer immunogenicity evidence relevant to booster vaccination strategy decisions during Omicron-era outbreaks, with particular relevance to settings where inactivated virus priming is used. COVID-19 SARS Vaccination Outbreak investigation Cohort study https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128993-5ff5f987/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128993-5ff5f987/ Tue, 01 Sep 2026 00:00:00 GMT These aggregated results guide international immunization planning and highlight structural improvements needed for future outbreak responses, such as unified research methodologies and integrated health databases. COVID-19 SARS Vaccination Vaccine effectiveness Systematic review https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-129009-9ffc71a1/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-129009-9ffc71a1/ Tue, 01 Sep 2026 00:00:00 GMT Findings support continued COVID-19 vaccine recommendations, demonstrating protection across the 2024-2025 season for adults including those with underlying medical conditions. COVID-19 Influenza Vaccination Vaccine effectiveness Cohort study https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-129030-f0002f3e/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-129030-f0002f3e/ Tue, 01 Sep 2026 00:00:00 GMT The findings indicate that JN.1 vaccination provided limited additional protection against SARS-CoV-2 infection during a low-incidence period, with modest effectiveness observed in both age groups. The results contribute to understanding the real-world performance of updated COVID-19 vaccines against emerging subvariants. SARS COVID-19 Vaccination Cohort study https://globalinfectiousdisease.com/research/articles/10-7417-ct-2026-2101-5a39d970/ https://globalinfectiousdisease.com/research/articles/10-7417-ct-2026-2101-5a39d970/ Tue, 01 Sep 2026 00:00:00 GMT The article supports a shift from narrow infection prevention strategies to integrated approaches that address both biological and psychosocial occupational hazards, potentially improving healthcare workforce sustainability and system resilience. COVID-19 SARS Surveillance Outbreak investigation Transmission dynamics Journal article https://globalinfectiousdisease.com/research/articles/10-1371-journal-pdig-0001473-f2024cba/ https://globalinfectiousdisease.com/research/articles/10-1371-journal-pdig-0001473-f2024cba/ Mon, 31 Aug 2026 00:00:00 GMT Centralizing genomic and clinical data streams allows continuous assessment of viral behavior and transmission networks across a large jurisdiction. The established pipeline offers a replicable template for health departments aiming to strengthen routine variant tracking and resource allocation. SARS COVID-19 Genomic epidemiology Surveillance Transmission dynamics Vaccination Genomic study https://globalinfectiousdisease.com/research/articles/10-24171-j-phrp-2026-0226-be859bcd/ https://globalinfectiousdisease.com/research/articles/10-24171-j-phrp-2026-0226-be859bcd/ Mon, 31 Aug 2026 00:00:00 GMT The observed decline in diagnostic verification alongside sustained mortality suggests potential gaps in current monitoring frameworks. Recognizing environmental drivers and integrating cross-sectoral health approaches could strengthen future outbreak preparedness and response strategies. Lassa COVID-19 Climate and environment Surveillance One Health Ecological study https://globalinfectiousdisease.com/research/articles/10-1158-2159-8290-cd-26-0403-4efecc0b/ https://globalinfectiousdisease.com/research/articles/10-1158-2159-8290-cd-26-0403-4efecc0b/ Fri, 28 Aug 2026 00:00:00 GMT Within the supplied cancer-care cohorts, the findings do not support interpreting peri-treatment SARS-CoV-2 mRNA vaccination as improving immunotherapy-related survival. The abstract describes the observed early-pandemic association as largely attributable to selection bias involving more favorable-prognosis patients. SARS COVID-19 Vaccination Treatment Journal article https://globalinfectiousdisease.com/research/articles/10-1007-s12311-026-02074-3-199c1b40/ https://globalinfectiousdisease.com/research/articles/10-1007-s12311-026-02074-3-199c1b40/ Thu, 27 Aug 2026 00:00:00 GMT The review maps the clinical spectrum of an immune-mediated post-infectious neurological syndrome across age groups and common viral triggers, which may inform recognition of ataxia syndromes following infection. COVID-19 SARS Varicella Influenza Zoster Treatment Vaccination Systematic review https://globalinfectiousdisease.com/research/articles/10-1093-ofid-ofag522-4f2a4986/ https://globalinfectiousdisease.com/research/articles/10-1093-ofid-ofag522-4f2a4986/ Thu, 27 Aug 2026 00:00:00 GMT The results suggest that deploying this specific immunization strategy may help curb institutional transmission episodes during years with active seasonal pathogen circulation, thereby potentially reducing operational disruptions within elderly care infrastructure. Influenza COVID-19 Vaccination Treatment Outbreak investigation Transmission dynamics Journal article https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-14296-1-f04d486a/ https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-14296-1-f04d486a/ Thu, 27 Aug 2026 00:00:00 GMT The findings suggest that relying on reporting dates in surveillance systems may underestimate real-time transmission intensity and distort epidemic risk assessment in childcare settings, which are high-risk environments for respiratory virus transmission. COVID-19 SARS Surveillance Outbreak investigation Transmission dynamics Journal article https://globalinfectiousdisease.com/research/articles/10-1038-s41467-026-76465-9-6ca54143/ https://globalinfectiousdisease.com/research/articles/10-1038-s41467-026-76465-9-6ca54143/ Wed, 26 Aug 2026 00:00:00 GMT The study demonstrates a potential sustained protein-delivery platform and motivates further exploration of transgenic schistosomes as living-foundry therapeutics. SARS COVID-19 Transmission dynamics Treatment Journal article https://globalinfectiousdisease.com/research/articles/10-1007-s15010-026-02917-5-60e9f363/ https://globalinfectiousdisease.com/research/articles/10-1007-s15010-026-02917-5-60e9f363/ Tue, 25 Aug 2026 00:00:00 GMT The authors propose that community-based screening can help identify asymptomatic viral reservoirs and underreported viral circulation, such as adenovirus, linking viral detection to clinical and economic impact. SARS COVID-19 Influenza Surveillance Vaccination Journal article https://globalinfectiousdisease.com/research/articles/10-1016-j-sbi-2026-103375-5f324c76/ https://globalinfectiousdisease.com/research/articles/10-1016-j-sbi-2026-103375-5f324c76/ Tue, 25 Aug 2026 00:00:00 GMT The article may inform research prioritization around extracellular-vesicle characterization, biomarker development, and therapeutic-platform evaluation for COVID-19 and long COVID. The supplied abstract does not establish clinical effectiveness, population-level impact, or readiness for public-health implementation. COVID-19 SARS Diagnostics Treatment Journal article https://globalinfectiousdisease.com/research/articles/10-1038-s41467-026-75748-5-6d7271df/ https://globalinfectiousdisease.com/research/articles/10-1038-s41467-026-75748-5-6d7271df/ Tue, 25 Aug 2026 00:00:00 GMT The demonstration of shared immune alterations across distinct critical illnesses suggests that similar targeted immunomodulation strategies may benefit multiple patient populations in intensive care settings. COVID-19 SARS Cohort study https://globalinfectiousdisease.com/research/articles/10-1177-2752535x261481203-1656f630/ https://globalinfectiousdisease.com/research/articles/10-1177-2752535x261481203-1656f630/ Tue, 25 Aug 2026 00:00:00 GMT Identifying these community-specific viewpoints can help shape targeted educational initiatives that address information gaps and strengthen local engagement strategies. COVID-19 Influenza Vaccination Commentary https://globalinfectiousdisease.com/research/articles/10-1186-s40249-026-01491-0-094906d7/ https://globalinfectiousdisease.com/research/articles/10-1186-s40249-026-01491-0-094906d7/ Tue, 25 Aug 2026 00:00:00 GMT The results emphasize the importance of predictable domestic funding, robust monitoring systems, and sustainable local partnerships to maintain endemic disease control during systemic crises. COVID-19 SARS One Health Treatment Surveillance Health policy Commentary https://globalinfectiousdisease.com/research/articles/10-33321-cdi-2026-50-021-5d1ab8a5/ https://globalinfectiousdisease.com/research/articles/10-33321-cdi-2026-50-021-5d1ab8a5/ Tue, 25 Aug 2026 00:00:00 GMT The report documents an unprecedented two-year suppression of influenza activity in Australia concurrent with COVID-19 PHSMs, providing a descriptive baseline relevant to understanding how non-pharmaceutical measures and pandemic-era conditions can shape seasonal influenza epidemiology. Influenza COVID-19 Surveillance Journal article https://globalinfectiousdisease.com/research/articles/10-1080-22221751-2026-2716499-8ada39ff/ https://globalinfectiousdisease.com/research/articles/10-1080-22221751-2026-2716499-8ada39ff/ Mon, 24 Aug 2026 00:00:00 GMT The paper is relevant to outbreak preparedness because it describes a rapid antigen test intended for Nipah virus detection in settings where nucleic-acid testing may be difficult to use. The abstract frames the assay as potentially useful for point-of-care diagnosis in resource-limited contexts. MERS SARS COVID-19 Measles Influenza Diagnostics Outbreak investigation One Health Journal article https://globalinfectiousdisease.com/research/articles/10-1093-intimm-dxag045-315c0bb4/ https://globalinfectiousdisease.com/research/articles/10-1093-intimm-dxag045-315c0bb4/ Mon, 24 Aug 2026 00:00:00 GMT The findings suggest BNT162b2 mRNA vaccination induces both effector and regulatory T cell responses to spike antigen, indicating that Treg co-induction may be important for balancing antiviral immunity with immunoregulation during COVID-19 vaccination. COVID-19 SARS Vaccination Journal article https://globalinfectiousdisease.com/research/articles/10-3389-fimmu-2026-1908452-606ef91e/ https://globalinfectiousdisease.com/research/articles/10-3389-fimmu-2026-1908452-606ef91e/ Mon, 24 Aug 2026 00:00:00 GMT The findings suggest that inflammatory and iron metabolism biomarkers may help stratify COVID-19 severity and identify mechanisms underlying disease progression, including persistent pathology in severe long COVID-19. COVID-19 Vaccination Case-control study https://globalinfectiousdisease.com/research/articles/10-3390-gastroent17030047-7c785cda/ https://globalinfectiousdisease.com/research/articles/10-3390-gastroent17030047-7c785cda/ Mon, 24 Aug 2026 00:00:00 GMT The authors note severe upper GI bleeding is rare in children with SARS-CoV-2 infection and MIS-C, and that bleeding occurred despite continuous PPI prophylaxis, suggesting consideration of risk-factor-based prophylaxis and monitoring of vitamin K-dependent coagulation in critically ill children on high-dose corticosteroids and prolonged broad-spectrum antibiotics. SARS COVID-19 Treatment Journal article https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciag515-2efdbca0/ https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciag515-2efdbca0/ Sat, 22 Aug 2026 00:00:00 GMT The findings indicate that changes in the pertussis case definition affect interpretation of reported disease trends over time. The abstract describes the 2020 definition change as contributing to the magnitude of the reported 2024 increase. Pertussis COVID-19 Surveillance Journal article https://globalinfectiousdisease.com/research/articles/10-1007-s40471-026-00405-w-511150c9/ https://globalinfectiousdisease.com/research/articles/10-1007-s40471-026-00405-w-511150c9/ Fri, 21 Aug 2026 00:00:00 GMT Clarifying the scope and availability of these monitoring frameworks may streamline epidemiological investigations and support more effective emergency management strategies. SARS COVID-19 Influenza Surveillance Outbreak investigation Health policy Journal article https://globalinfectiousdisease.com/research/articles/10-1097-md-0000000000050329-08341cfe/ https://globalinfectiousdisease.com/research/articles/10-1097-md-0000000000050329-08341cfe/ Fri, 21 Aug 2026 00:00:00 GMT The familial clustering suggests that genetic factors beyond RANBP2 may predispose individuals to ANE following COVID-19. Early recognition of neurological deterioration and prompt MRI evaluation may enable timely immunomodulatory treatment. COVID-19 SARS Treatment Journal article https://globalinfectiousdisease.com/research/articles/10-3390-v18080923-cd6d1a13/ https://globalinfectiousdisease.com/research/articles/10-3390-v18080923-cd6d1a13/ Fri, 21 Aug 2026 00:00:00 GMT The methodology supports large-scale tracking of pharmaceutical resistance and viral adaptation markers, indicating potential value for expanding community-level monitoring initiatives. SARS COVID-19 Surveillance Genomic epidemiology Treatment Journal article https://globalinfectiousdisease.com/research/articles/10-54117-5j8z2m06-37e1c154/ https://globalinfectiousdisease.com/research/articles/10-54117-5j8z2m06-37e1c154/ Fri, 21 Aug 2026 00:00:00 GMT The paper calls for stronger emissions controls, cleaner energy policies, and further multidisciplinary research based on its proposed framework. These are recommendations made by the authors and are not independently validated by the supplied evidence. COVID-19 SARS Climate and environment Transmission dynamics Commentary https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-14277-4-5dc193bf/ https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-14277-4-5dc193bf/ Thu, 20 Aug 2026 00:00:00 GMT The findings are positioned to inform antibiotic stewardship and hospital infection control by highlighting temporal shifts in K. pneumoniae epidemiology and resistance patterns around the pandemic transition. COVID-19 Antimicrobial resistance Journal article https://globalinfectiousdisease.com/research/articles/10-1371-journal-pone-0354686-b7a695f9/ https://globalinfectiousdisease.com/research/articles/10-1371-journal-pone-0354686-b7a695f9/ Thu, 20 Aug 2026 00:00:00 GMT The findings are framed as informing future CDC messaging during outbreaks, recommending that communication be free from perceived political bias and grounded in evidence-based information shared with healthcare workers. COVID-19 Vaccination Commentary https://globalinfectiousdisease.com/research/articles/10-3389-fimmu-2026-1846973-b86af0be/ https://globalinfectiousdisease.com/research/articles/10-3389-fimmu-2026-1846973-b86af0be/ Thu, 20 Aug 2026 00:00:00 GMT The work addresses how putative epistatic spike mutations in XBB.1.16 may contribute to immune evasion and variant dominance, relevant to understanding SARS-CoV-2 evolutionary trajectories. SARS COVID-19 Vaccination Journal article https://globalinfectiousdisease.com/research/articles/10-3389-fpubh-2026-1807183-3086719d/ https://globalinfectiousdisease.com/research/articles/10-3389-fpubh-2026-1807183-3086719d/ Thu, 20 Aug 2026 00:00:00 GMT Identifying specific informational gaps and behavioral barriers supports the development of focused outreach initiatives. Aligning communication strategies with established community trust networks could enhance engagement with integrated disease management approaches. Dengue COVID-19 Vaccination Transmission dynamics Vaccine safety Cross-sectional study https://globalinfectiousdisease.com/research/articles/10-3390-covid6080148-2608d6ae/ https://globalinfectiousdisease.com/research/articles/10-3390-covid6080148-2608d6ae/ Thu, 20 Aug 2026 00:00:00 GMT The work addresses food security, a key public health concern, by linking pandemic-related value chain disruption in the Global South to policy options for resilience. COVID-19 Health policy Journal article https://globalinfectiousdisease.com/research/articles/10-3390-vaccines14080717-24db60bc/ https://globalinfectiousdisease.com/research/articles/10-3390-vaccines14080717-24db60bc/ Thu, 20 Aug 2026 00:00:00 GMT The authors frame the findings as relevant to vaccination policy, arguing that controlling for healthy-vaccinee bias is important when comparing vaccine effectiveness and that, during a period of high vaccine availability and COVID-19 mortality, Moderna was associated with lower COVID-19 mortality than Pfizer. A higher Moderna dose is suggested as a possible explanation. COVID-19 Vaccination Vaccine effectiveness Health policy Journal article https://globalinfectiousdisease.com/research/articles/10-1038-s41598-026-64718-y-dae61a8e/ https://globalinfectiousdisease.com/research/articles/10-1038-s41598-026-64718-y-dae61a8e/ Wed, 19 Aug 2026 00:00:00 GMT Results provide descriptive context for tracking public attention cycles and evaluating the communicative impact of operational health interventions during crises. COVID-19 Outbreak investigation Journal article https://globalinfectiousdisease.com/research/articles/10-1128-aem-00757-26-05c365cd/ https://globalinfectiousdisease.com/research/articles/10-1128-aem-00757-26-05c365cd/ Wed, 19 Aug 2026 00:00:00 GMT Implementing affordable environmental monitoring could strengthen early warning capabilities within congregate living arrangements. Establishing standardized operational procedures alongside environmental tracking may improve institutional readiness during infectious disease events. SARS COVID-19 Influenza Surveillance Outbreak investigation Journal article https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13588-w-e7170c47/ https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13588-w-e7170c47/ Wed, 19 Aug 2026 00:00:00 GMT Findings suggest nirmatrelvir/ritonavir may reduce risks of both acute severe outcomes and post-acute sequelae including long-COVID in high-risk outpatient populations, supporting continued use as a therapeutic option. COVID-19 SARS Treatment Cohort study https://globalinfectiousdisease.com/research/articles/10-14746-pp-2026-31-2-9-244d3704/ https://globalinfectiousdisease.com/research/articles/10-14746-pp-2026-31-2-9-244d3704/ Wed, 19 Aug 2026 00:00:00 GMT The findings document policy responses aimed at mitigating economic consequences of pandemic-related disruptions, including effects on employment and business continuity. COVID-19 Health policy Journal article https://globalinfectiousdisease.com/research/articles/10-1038-s41541-026-01549-y-025f7ccf/ https://globalinfectiousdisease.com/research/articles/10-1038-s41541-026-01549-y-025f7ccf/ Tue, 18 Aug 2026 00:00:00 GMT The reported durability and breadth of the cellular response suggest a potential strategy to overcome the immune evasion and waning protection associated with current spike-focused immunizations. COVID-19 SARS MERS Vaccination Vaccine effectiveness Journal article https://globalinfectiousdisease.com/research/articles/10-1038-s41591-026-04561-w-113aa29d/ https://globalinfectiousdisease.com/research/articles/10-1038-s41591-026-04561-w-113aa29d/ Tue, 18 Aug 2026 00:00:00 GMT The abstract indicates potential relevance for assessing measles vulnerability and for considering vaccination and outbreak-monitoring approaches at school and district levels. These implications are model-based and do not establish that a current surveillance signal has been confirmed. Measles COVID-19 Transmission dynamics Vaccination Outbreak investigation Surveillance One Health Mathematical modelling https://globalinfectiousdisease.com/research/articles/10-1128-jvi-00401-26-8ade0a81/ https://globalinfectiousdisease.com/research/articles/10-1128-jvi-00401-26-8ade0a81/ Tue, 18 Aug 2026 00:00:00 GMT The abstract highlights a four-fold higher incidence of pulmonary PASC among those with type 2 diabetes and positions GLP-1 receptor agonists as a candidate therapeutic strategy in this population. COVID-19 SARS Treatment Journal article https://globalinfectiousdisease.com/research/articles/10-1186-s43168-026-00652-x-17423b60/ https://globalinfectiousdisease.com/research/articles/10-1186-s43168-026-00652-x-17423b60/ Tue, 18 Aug 2026 00:00:00 GMT The study identifies potential therapeutic targets for reducing SARS-CoV-2 infection risk in NSCLC patients through modulation of receptor expression, particularly ACE2 and TMPRSS2. COVID-19 SARS Treatment Journal article https://globalinfectiousdisease.com/research/articles/10-29303-jbt-v26i3-12221-4e73c5cb/ https://globalinfectiousdisease.com/research/articles/10-29303-jbt-v26i3-12221-4e73c5cb/ Tue, 18 Aug 2026 00:00:00 GMT The findings provide computational evidence for prioritizing carotenoid–RdRp interactions in early antiviral research involving Pandanus conoideus. They do not establish antiviral activity, therapeutic effectiveness, or relevance to patient outcomes. SARS COVID-19 Treatment Journal article https://globalinfectiousdisease.com/research/articles/10-3389-fmicb-2026-1854041-de0c12b1/ https://globalinfectiousdisease.com/research/articles/10-3389-fmicb-2026-1854041-de0c12b1/ Tue, 18 Aug 2026 00:00:00 GMT Sustained environmental tracking may offer supplementary insights for anticipating healthcare resource requirements and monitoring ongoing respiratory pathogen circulation. SARS COVID-19 Surveillance Outbreak investigation Vaccination Climate and environment Journal article https://globalinfectiousdisease.com/research/articles/10-3390-medicina62081584-c6ea2e78/ https://globalinfectiousdisease.com/research/articles/10-3390-medicina62081584-c6ea2e78/ Tue, 18 Aug 2026 00:00:00 GMT Identifying specific demographic and treatment-related markers of nutritional decline supports the development of focused monitoring protocols for vulnerable oncology populations during extended public health emergencies. COVID-19 SARS Transmission dynamics Vaccination Treatment Journal article https://globalinfectiousdisease.com/research/articles/10-3390-vaccines14080709-dbfd1331/ https://globalinfectiousdisease.com/research/articles/10-3390-vaccines14080709-dbfd1331/ Tue, 18 Aug 2026 00:00:00 GMT The discussion addresses persistent worldwide influenza burdens and outlines practical barriers to broad deployment, including production volume, financial constraints, temperature-controlled storage demands, and equitable international distribution. Influenza SARS COVID-19 Vaccination Surveillance Commentary https://globalinfectiousdisease.com/research/articles/10-1021-acsanm-6c02570-1f62847d/ https://globalinfectiousdisease.com/research/articles/10-1021-acsanm-6c02570-1f62847d/ Mon, 17 Aug 2026 00:00:00 GMT Avian influenza is described as a threat to the poultry industry and public health, motivating alternative vaccine platforms beyond conventional egg-based inactivated vaccines; an effective mRNA-based avian vaccine could support both animal and potentially zoonotic disease control. Influenza COVID-19 Vaccination Journal article https://globalinfectiousdisease.com/research/articles/10-1371-journal-pone-0354822-21d017fb/ https://globalinfectiousdisease.com/research/articles/10-1371-journal-pone-0354822-21d017fb/ Mon, 17 Aug 2026 00:00:00 GMT The findings can inform decision-making, public health strategies, and policy development to protect vaccinated populations at elevated risk. The results support recommendations from Canada's National Advisory Committee on Immunisation for specific groups to remain current with COVID-19 vaccination to reduce severe outcomes. COVID-19 SARS Vaccination Health policy Cohort study